OVERVIEW
Costimulatory molecules have an important role in T cell-mediated immune responses and the maintenance of T cell tolerance. Better understanding of the complexities of the costimulatory pathways has facilitated the use of costimulatory blockade to modulate alloimmune responses and prolong graft survival. In this upcoming live event, an expert panel will discuss the role of costimulatory pathways in transplantation and therapeutic targets in the costimulatory pathways.
GOAL STATEMENT
The goal of this activity is for learners to better understand the role of costimulatory pathways and targets in transplantation and to apply lessons learned from the past few decades to future clinical trial design for emerging costimulatory blocking therapeutics.
LEARNING OBJECTIVES
Upon completion of this activity, participants will: Have greater competence related to[list][item]Describing the role of costimulatory pathways in transplantation[item]Developing impactful clinical trial design for emerging costimulatory therapeutics[/list]Demonstrate greater confidence in their ability to[list][item]Recognize therapeutic targets in the costimulation pathway[/list]
ACCREDITATION STATEMENT
[JALOGO][MEDSCAPE] In support of improving patient care, Medscape, LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
[bold]For Physicians[/bold] Medscape, LLC designates this live activity for a maximum of [bold][italic]1.0 AMA PRA Category 1 Credits™[/bold][/italic]. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
MANCHESTER GRAND HYATT SAN DIEGO
1 MARKET PL Room: Grand Ballroom A
SAN DIEGO, CALIFORNIA, 92101-7714
THIS SYMPOSIUM IS NOT PART OF THE ATC OFFICIAL EDUCATIONAL PROGRAM AND THE SESSIONS AND CONTENT ARE NOT ENDORSED BY ATC.
Supported by an independent educational grant from [bold]Veloxis[/bold]